MENU
CYCC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cyclacel Pharmaceuticals (CYCC) Ownership - Who owns Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases... Show more

Profile

Industry
N/A
Address
200 Connell Drive
Phone
+1 908 517-7330
Employees
12
Web
https://cyclacel.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
14.25M
P/E Ratio
0.00
Total Cash
4.28M
Projected Growth
N/A
Total Debt
10K
Revenue
10K
Risk (Beta)
-1.06
Dividend Yield
N/A
Total Cash/Share
1.91
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
200 Connell Drive
Phone
+1 908 517-7330
Employees
12
Web
https://cyclacel.com